Toggle navigation
Home
Search
Services
Blog
Contact
About
Anti Tach H Therapy in Leukemia and Lymphoma
Junghans, Richard P.
Beth Israel Deaconess Medical Center, Boston, MA, United States
Search 40 grants from Richard Junghans
Search grants from Beth Israel Deaconess Medical Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Estrogen receptors and TrkB mediated neuroprotection in neonatal hypoxia-ischemia
Mechanism of action of C. perfringens enterotoxin
Section on Light and Circadian Rhythms
Membrane protein structure in lipido: computational developments.
Transrectal Prostate Therapy Robot in Closed MRI Scanner
Recently added grants:
The impact of reduced blood flow early in Alzheimer's disease on neuronal function.
Contribution of peripheral immune dysregulation to Alzheimer's disease
Sensitive and quantitative malaria diagnostic using nanoscale porous silicon.
Tetrahydrothieno[2,3-c]pyridines as Vaccine Co-adjuvants
Neurogenetic Mechanisms Controlling Functional Maturation of Neural Circuits and Behavior
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA067079-02
Application #
2110655
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1995-04-01
Project End
1997-03-31
Budget Start
1996-04-01
Budget End
1997-03-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Related projects
NIH 1996
R03 CA
Anti Tach H Therapy in Leukemia and Lymphoma
Junghans, Richard P. / Beth Israel Deaconess Medical Center
NIH 1995
R03 CA
Anti Tach H Therapy in Leukemia and Lymphoma
Junghans, Richard P. / Beth Israel Deaconess Medical Center
Comments
Be the first to comment on Richard Junghans's grant